Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug].

× No keyword cloud information.

14 in total

1. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Authors: L Hansson; L H Lindholm; L Niskanen; J Lanke; T Hedner; A Niklason; K Luomanmäki; B Dahlöf; U de Faire; C Mörlin; B E Karlberg; P O Wester; J E Björck
Journal: Lancet Date: 1999-02-20 Impact factor: 79.321

2. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

3. Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study.

Authors: K B Michels; B A Rosner; J E Manson; M J Stampfer; A M Walker; W C Willett; C H Hennekens
Journal: Circulation Date: 1998-04-28 Impact factor: 29.690

4. Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction.

Authors: Harm Wienbergen; Rudolf Schiele; Anselm Kai Gitt; Claus Juenger; Tobias Heer; Christina Meisenzahl; Helmut Landgraf; Claus Bossaller; Jochen Senges
Journal: Am J Cardiol Date: 2002-11-15 Impact factor: 2.778

5. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Authors:
Journal: JAMA Date: 2000-04-19 Impact factor: 56.272

6. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Authors: Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West
Journal: N Engl J Med Date: 2003-02-13 Impact factor: 91.245

7. Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial.

Authors: E P Walma; A W Hoes; C van Dooren; A Prins; E van der Does
Journal: BMJ Date: 1997-08-23

8. Optimisation of antihypertensive treatment by crossover rotation of four major classes.

Authors: J E Dickerson; A D Hingorani; M J Ashby; C R Palmer; M J Brown
Journal: Lancet Date: 1999-06-12 Impact factor: 79.321

9. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal: Lancet Date: 2002-03-23 Impact factor: 79.321

Review 10. Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors: B N Prichard; R N Brogden
Journal: Drugs Date: 1985-10 Impact factor: 9.546